DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
In a new twist on Wednesday, a DEA judge ordered the agency to respond to allegations that it opposes President Joe Biden's ...
Cannabis and Trump 2.0: 2025 and beyond
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
Cannabis companies say DEA has closed mind against a less-dangerous pot ranking
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...
Cannabis Stocks Dive After DEA Accused of Hindering Rescheduling
Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.
DEA Agent Gets New Shot at Early Promotion, Judges Panel Rules
The Merit Systems Protection Board needs to examine if the US government incorrectly denied a DEA agent a promotion for more ...